tiprankstipranks
IQVIA Holdings Inc (IQV)
NYSE:IQV
US Market
IQV
IQVIA Holdings
RESEARCH TOOLSreports
Want to see IQV full AI Analyst Report?

IQVIA Holdings (IQV) Stock Forecast & Price Target

1,048 Followers
See the Price Targets and Ratings of:

IQV Analyst Ratings

Strong Buy
12Ratings
Strong Buy
11 Buy
1 Hold
0 Sell
Based on 12 analysts giving stock ratings to
IQVIA
Holdings
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

IQV Stock 12 Month Forecast

Average Price Target

$215.90
▲(22.35% Upside)
Based on 12 Wall Street analysts offering 12 month price targets for IQVIA Holdings in the last 3 months. The average price target is $215.90 with a high forecast of $245.00 and a low forecast of $185.00. The average price target represents a 22.35% change from the last price of $176.46.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"138":"$138","165":"$165","192":"$192","219":"$219","246":"$246"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":245,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$245.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":215.9,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$215.90</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":185,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$185.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[138,165,192,219,246],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,157.77,164.48000000000002,171.19,177.9,184.61,191.32,198.03,204.74,211.45,218.16,224.87,231.57999999999998,238.29,{"y":245,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,157.77,162.24153846153848,166.71307692307693,171.1846153846154,175.65615384615387,180.1276923076923,184.5992307692308,189.07076923076923,193.5423076923077,198.01384615384615,202.48538461538462,206.9569230769231,211.42846153846153,{"y":215.9,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,157.77,159.8646153846154,161.95923076923077,164.05384615384617,166.14846153846153,168.24307692307693,170.33769230769232,172.4323076923077,174.52692307692308,176.62153846153848,178.71615384615384,180.81076923076924,182.9053846153846,{"y":185,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":151.1,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":139.1,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":162.61,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":182.45,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":183.74,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":203.79,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":216.46,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":228.47,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":225.41,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":231.23,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":174.27,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":172.4,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":157.77,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$245.00Average Price Target$215.90Lowest Price Target$185.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Truist Financial Analyst forecast on IQV
Jailendra Singh
Truist Financial
Truist Financial
―
Buy
―
Reiterated
05/14/26
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (NYSE: IQV), BeOne Medicines (NASDAQ: ONC) and Nektar Therapeutics (NASDAQ: NKTR)
Bank of America Securities Analyst forecast on IQV
Michael Ryskin
Bank of America Securities
Bank of America Securities
$245
Buy
38.84%
Upside
Reiterated
05/13/26
Analyst Reiterates Buy on IQVIA After Strong Q1 Beat, Reaffirmed Outlook, and AI-Driven Growth Prospects
BMO Capital Analyst forecast on IQV
Sean Dodge
BMO Capital
BMO Capital
$210
Buy
19.01%
Upside
Assigned
05/08/26
IQVIA: Buy Rating Reiterated on Resilient Fundamentals and AI-Driven Growth Despite Price Target Cut to $210
Jefferies Analyst forecast on IQV
Unknown Analyst
Jefferies
Not Ranked
Jefferies
$220
Buy
24.67%
Upside
Reiterated
05/06/26
Jefferies Keeps Their Buy Rating on IQVIA Holdings (IQV)
Barclays Analyst forecast on IQV
Luke Sergott
Barclays
Barclays
$210
Buy
19.01%
Upside
Reiterated
05/06/26
Barclays Sticks to Their Buy Rating for IQVIA Holdings (IQV)
TD Cowen Analyst forecast on IQV
Charles Rhyee
TD Cowen
TD Cowen
$213
Buy
20.71%
Upside
Reiterated
05/05/26
IQVIA: Buy Rating Reaffirmed, $213 Price Target Maintained on Solid B2B Momentum and Margin Outlook
Morgan Stanley Analyst forecast on IQV
Kallum Titchmarsh
Morgan Stanley
Morgan Stanley
$240
Buy
36.01%
Upside
Reiterated
05/05/26
IQVIA: Buy Rating Reiterated on Solid Growth and Valuation, $240 Price Target Unchanged
RBC Capital Analyst forecast on IQV
Ryan Halsted
RBC Capital
RBC Capital
$221
Buy
25.24%
Upside
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (NYSE: IQV), Contineum Therapeutics, Inc. Class A (NASDAQ: CTNM) and Exelixis (NASDAQ: EXEL)
William Blair Analyst forecast on IQV
Max Smock
William Blair
William Blair
―
Buy
―
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: Repligen (NASDAQ: RGEN) and IQVIA Holdings (NYSE: IQV)
Evercore ISI Analyst forecast on IQV
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
$225→$185
Buy
4.84%
Upside
Reiterated
04/08/26
Iqvia price target lowered to $185 from $225 at Evercore ISIIqvia price target lowered to $185 from $225 at Evercore ISI
Citi Analyst forecast on IQV
Patrick B Donnelly
Citi
Citi
$200
Hold
13.34%
Upside
Assigned
04/07/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Opus Genetics (NASDAQ: IRD) and IQVIA Holdings (NYSE: IQV)
Mizuho Securities Analyst forecast on IQV
Ann Hynes
Mizuho Securities
Mizuho Securities
$266→$215
Buy
21.84%
Upside
Reiterated
02/23/26
Iqvia price target lowered to $215 from $266 at MizuhoIqvia price target lowered to $215 from $266 at Mizuho
UBS Analyst forecast on IQV
Dan Leonard
UBS
UBS
$280→$240
Buy
36.01%
Upside
Reiterated
02/06/26
Iqvia price target lowered to $240 from $280 at UBSIqvia price target lowered to $240 from $280 at UBS
Stifel Nicolaus Analyst forecast on IQV
Shlomo Rosenbaum
Stifel Nicolaus
Stifel Nicolaus
$273→$220
Buy
24.67%
Upside
Reiterated
02/06/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: IQVIA Holdings (NYSE: IQV), Qiagen (NYSE: QGEN) and Ligand Pharma (NASDAQ: LGND)
J.P. Morgan Analyst forecast on IQV
Anne Samuel
J.P. Morgan
J.P. Morgan
$255→$225
Buy
27.51%
Upside
Reiterated
02/06/26
Iqvia price target lowered to $225 from $255 at JPMorganIqvia price target lowered to $225 from $255 at JPMorgan
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Truist Financial Analyst forecast on IQV
Jailendra Singh
Truist Financial
Truist Financial
―
Buy
―
Reiterated
05/14/26
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (NYSE: IQV), BeOne Medicines (NASDAQ: ONC) and Nektar Therapeutics (NASDAQ: NKTR)
Bank of America Securities Analyst forecast on IQV
Michael Ryskin
Bank of America Securities
Bank of America Securities
$245
Buy
38.84%
Upside
Reiterated
05/13/26
Analyst Reiterates Buy on IQVIA After Strong Q1 Beat, Reaffirmed Outlook, and AI-Driven Growth Prospects
BMO Capital Analyst forecast on IQV
Sean Dodge
BMO Capital
BMO Capital
$210
Buy
19.01%
Upside
Assigned
05/08/26
IQVIA: Buy Rating Reiterated on Resilient Fundamentals and AI-Driven Growth Despite Price Target Cut to $210
Jefferies Analyst forecast on IQV
Unknown Analyst
Jefferies
Not Ranked
Jefferies
$220
Buy
24.67%
Upside
Reiterated
05/06/26
Jefferies Keeps Their Buy Rating on IQVIA Holdings (IQV)
Barclays Analyst forecast on IQV
Luke Sergott
Barclays
Barclays
$210
Buy
19.01%
Upside
Reiterated
05/06/26
Barclays Sticks to Their Buy Rating for IQVIA Holdings (IQV)
TD Cowen Analyst forecast on IQV
Charles Rhyee
TD Cowen
TD Cowen
$213
Buy
20.71%
Upside
Reiterated
05/05/26
IQVIA: Buy Rating Reaffirmed, $213 Price Target Maintained on Solid B2B Momentum and Margin Outlook
Morgan Stanley Analyst forecast on IQV
Kallum Titchmarsh
Morgan Stanley
Morgan Stanley
$240
Buy
36.01%
Upside
Reiterated
05/05/26
IQVIA: Buy Rating Reiterated on Solid Growth and Valuation, $240 Price Target Unchanged
RBC Capital Analyst forecast on IQV
Ryan Halsted
RBC Capital
RBC Capital
$221
Buy
25.24%
Upside
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (NYSE: IQV), Contineum Therapeutics, Inc. Class A (NASDAQ: CTNM) and Exelixis (NASDAQ: EXEL)
William Blair Analyst forecast on IQV
Max Smock
William Blair
William Blair
―
Buy
―
Reiterated
05/05/26
Analysts Offer Insights on Healthcare Companies: Repligen (NASDAQ: RGEN) and IQVIA Holdings (NYSE: IQV)
Evercore ISI Analyst forecast on IQV
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
$225→$185
Buy
4.84%
Upside
Reiterated
04/08/26
Iqvia price target lowered to $185 from $225 at Evercore ISIIqvia price target lowered to $185 from $225 at Evercore ISI
Citi Analyst forecast on IQV
Patrick B Donnelly
Citi
Citi
$200
Hold
13.34%
Upside
Assigned
04/07/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Opus Genetics (NASDAQ: IRD) and IQVIA Holdings (NYSE: IQV)
Mizuho Securities Analyst forecast on IQV
Ann Hynes
Mizuho Securities
Mizuho Securities
$266→$215
Buy
21.84%
Upside
Reiterated
02/23/26
Iqvia price target lowered to $215 from $266 at MizuhoIqvia price target lowered to $215 from $266 at Mizuho
UBS Analyst forecast on IQV
Dan Leonard
UBS
UBS
$280→$240
Buy
36.01%
Upside
Reiterated
02/06/26
Iqvia price target lowered to $240 from $280 at UBSIqvia price target lowered to $240 from $280 at UBS
Stifel Nicolaus Analyst forecast on IQV
Shlomo Rosenbaum
Stifel Nicolaus
Stifel Nicolaus
$273→$220
Buy
24.67%
Upside
Reiterated
02/06/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: IQVIA Holdings (NYSE: IQV), Qiagen (NYSE: QGEN) and Ligand Pharma (NASDAQ: LGND)
J.P. Morgan Analyst forecast on IQV
Anne Samuel
J.P. Morgan
J.P. Morgan
$255→$225
Buy
27.51%
Upside
Reiterated
02/06/26
Iqvia price target lowered to $225 from $255 at JPMorganIqvia price target lowered to $225 from $255 at JPMorgan
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering IQVIA Holdings

3 Months
xxx
Success Rate
21/32 ratings generated profit
66%
Average Return
+2.76%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 65.63% of your transactions generating a profit, with an average return of +2.76% per trade.
1 Year
Charles RhyeeTD Cowen
Success Rate
13/19 ratings generated profit
68%
Average Return
+9.06%
Copying Charles Rhyee's trades and holding each position for 1 Year would result in 68.42% of your transactions generating a profit, with an average return of +9.06% per trade.
2 Years
xxx
Success Rate
22/32 ratings generated profit
69%
Average Return
+6.35%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 68.75% of your transactions generating a profit, with an average return of +6.35% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

IQV Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
0
0
0
0
0
Buy
9
22
23
22
18
Hold
4
8
7
6
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
13
30
30
28
19
In the current month, IQV has received 18 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. IQV average Analyst price target in the past 3 months is 215.90.
Each month's total comprises the sum of three months' worth of ratings.

IQV Financial Forecast

IQV Earnings Forecast

Next quarter’s earnings estimate for IQV is $3.04 with a range of $3.00 to $3.10. The previous quarter’s EPS was $2.90. IQV beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year IQV has Performed in-line its overall industry.
Next quarter’s earnings estimate for IQV is $3.04 with a range of $3.00 to $3.10. The previous quarter’s EPS was $2.90. IQV beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year IQV has Performed in-line its overall industry.

IQV Sales Forecast

Next quarter’s sales forecast for IQV is $4.31B with a range of $4.28B to $4.34B. The previous quarter’s sales results were $4.16B. IQV beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year IQV has Performed in-line its overall industry.
Next quarter’s sales forecast for IQV is $4.31B with a range of $4.28B to $4.34B. The previous quarter’s sales results were $4.16B. IQV beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year IQV has Performed in-line its overall industry.

IQV Stock Forecast FAQ

What is IQV’s average 12-month price target, according to analysts?
Based on analyst ratings, IQVIA Holdings Inc’s 12-month average price target is 215.90.
    What is IQV’s upside potential, based on the analysts’ average price target?
    IQVIA Holdings Inc has 22.35% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is IQV a Buy, Sell or Hold?
          IQVIA Holdings Inc has a consensus rating of Strong Buy which is based on 11 buy ratings, 1 hold ratings and 0 sell ratings.
            What is IQVIA Holdings Inc’s price target?
            The average price target for IQVIA Holdings Inc is 215.90. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $245.00 ,the lowest forecast is $185.00. The average price target represents 22.35% Increase from the current price of $176.46.
              What do analysts say about IQVIA Holdings Inc?
              IQVIA Holdings Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.
                How can I buy shares of IQV?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.